PATIENT ELIGIBILITY

Offer the Cologuard® test to every eligible patient aged 45 and older at average risk for colorectal cancer (CRC)1

Chart showing which patients are eligible and not eligible to screen for CRC with a Cologuard test.
Cologuard box.

CRC screening guidelines

Discover which major CRC screening guidelines include the Cologuard test as a standard of care.

Learn More

This primary care physician chose the Cologuard test to screen himself for CRC

Dr Fenton is an average-risk patient with no family history of CRC. Watch how he caught CRC early.

Cologuard performance

Offer eligible patients high sensitivity and specificity with the Cologuard test

View the data
  • * Such as hereditary nonpolyposis CRC syndrome (or Lynch syndrome), Peutz-Jeghers syndrome, MYH-associated polyposis, Gardner’s syndrome, Turcot’s (or Crail’s) syndrome, Cowden’s syndrome, juvenile polyposis, Cronkhite-Canada syndrome, neurofibromatosis, or familiaI hyperplastic polyposis.1

FAP=familial adenomatous polyposis; IBD=inflammatory bowel disease; UC=ulcerative colitis.